Journal Mobile Options
Table of Contents
Vol. 38, No. 6, 2003
Issue release date: June 2003
Pediatr Neurosurg 2003;38:295–301
(DOI:10.1159/000070413)

The Influence of Surgical Operative Experience on the Duration of First Ventriculoperitoneal Shunt Function and Infection

Cochrane D.D. · Kestle J.R.W.
aDepartment of Surgery, University of British Columbia and Children’s and Women’s Health Center of British Columbia, Vancouver, B.C., Canada; bDepartment of Neurosurgery, University of Utah and Primary Children’s Medical Center, Salt Lake City, Utah, USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

The relationship of surgeon experience, measured by operative volume, to the outcomes of ventricular shunt treatment of hydrocephalus in children is not clear. This paper explores this relationship based on first ventriculoperitoneal shunts (VPS) implanted in English-speaking Canada during the period from April 1989 to March 2001. Three thousand seven hundred and ninety-four first VPS insertions, performed by 254 surgeons, were reviewed. Surgical experience was represented by the number of shunt operations performed during the study period by each surgeon prior to the date of the operation. The 6-month shunt failure risk for less experienced surgeons was 38%, compared to 31% for more experienced surgeons. This difference decreased to 4% at 60 months and 3% at 120 months (p = 0.001). The infection rate for initial shunt insertions was 7% for patients treated by more experienced surgeons and 9.4% for those treated by less experienced surgeons (p = 0.006). A relationship between surgeon experience and shunt outcome that appears to be based on the operative experience that a surgeon brings to a procedure is in keeping with clinical experience. This observation has implications for public policy, service planning and surgical mentorship during the earlier years of a surgeon’s career.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Drake JM, Kestle JR, Milner R, Cinalli G, Boop F, Piatt J Jr, et al: Randomized trial of cerebrospinal fluid shunt valve design in pediatric hydrocephalus. Neurosurgery 1998;43:294–305.
  2. Drake JM, Kestle J: Rationale and methodology of the multicenter pediatric cerebrospinal fluid shunt design trial. Pediatric Hydrocephalus Treatment Evaluation Group. Childs Nerv Syst 1996;12:434–447.
  3. Cochrane D, Kestle J, Steinbok P, Evans D, Heron N: Model for the cost analysis of shunted hydrocephalic children. Pediatr Neurosurg 1995;23:14–19.
  4. Sainte-Rose C, Piatt JH, Renier D, Pierre-Kahn A, Hirsch JF, Hoffman JH, et al: Mechanical complications in shunts. Pediatr Neurosurg 1991;92:2–9.
  5. Piatt JH Jr: Cerebrospinal fluid shunt failure: Late is different from early. Pediatr Neurosurg 1995;23:133–139.
  6. Piatt JH, Carlson CV: A search for determinants of cerebrospinal fluid shunt survival: Retrospective analysis of a 14-year institutional experience. Pediatr Neurosurg 1993;19:233–242.
  7. Lund-Johansen M, Svendsen F, Wester K: Shunt failures and complications in adults as related to shunt type, diagnosis, and the experience of the surgeon. Neurosurgery 1994;35:839–844.
  8. Kestle J, Milner R, Drake J: The Shunt Design Trial: Variation in surgical experience did not influence shunt survival. Pediatr Neurosurg 1999;30:283–287.
  9. Pollack IF, Albright AL, Adelson PD: A randomized, controlled study of a programmable shunt valve versus a conventional valve for patients with hydrocephalus. Hakim-Medos Investigator Group. Neurosurgery 1999;45:1399–1411.
  10. Luft HS, Garnick DW, Mark DH, McPhee SJ: Hospital Volume, Physician Volume, and Patient Outcomes: Assessing the Evidence. Ann Arbor, Health Administration Press, 1990.
  11. Espehaug B, Havelin LI, Engesaeter LB, Vollset SE: The effect of hospital-type and operating volume on the survival of hip replacements. A review of 39,505 primary total hip replacements reported to the Norwegian Arthroplasty Register, 1988–1996. Acta Orthop Scand 1999;70:12–18.
  12. Ellison LM, Heaney JA, Birkmeyer JD: The effect of hospital volume on mortality and resource use after radical prostatectomy. J Urol 2000;163:867–869.
  13. Hillner BE, Smith TJ, Desch CE: Hospital and physician volume or specialization and outcomes in cancer treatment: Importance in quality of cancer care. J Clin Oncol 2000;18:2327–2340.
  14. O’Neill L, Lanska DJ, Hartz A: Surgeon characteristics associated with mortality and morbidity following carotid endarterectomy. Neurology 2000;55:773–781.
  15. Pearce WH, Parker MA, Feinglass J, Ujiki M, Manheim LM: The importance of surgeon volume and training in outcomes for vascular surgical procedures. J Vasc Surg 1999;29:768–778.
  16. Sosa JA, Bowman, HM, Gordon TA, Bass EB, Yeo CJ, Lillemoe KD, et al: Importance of hospital volume in the overall management of pancreatic cancer. Ann Surg 1998;228:429–438.
  17. Sosa JA, Bowman HM, Tielsch JM, Powe NR, Gordon TA, Udelsman R: The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg 1998;228:320–330.
  18. Birkmeyer JD, Finlayson SR, Tosteson AN, Sharp SM, Warshaw AL, Fisher ES: Effect of hospital volume on in-hospital mortality with pancreaticoduodenectomy. Surgery 1999;125:250–256.
  19. Birkmeyer JD, Warshaw AL, Finlayson SR, Grove MR, Tosteson AN: Relationship between hospital volume and late survival after pancreaticoduodenectomy. Surgery 1999;126:178–183.
  20. Bach P, Cramer L, Schrag D, Downey R, Gelfanc S, Begg C: The influence of hospital volume on survival after resection for lung cancer. N Engl J Med 2001;345:181–188.
  21. Parry JM, Collins S, Mathers J, Scott NA, Woodman CB: Influence of volume of work on the outcome of treatment for patients with colorectal cancer. Br J Surg 1999;86:475–481.
  22. Crawford FA Jr, Anderson RP, Clark RE, Grover FL, Kouchoukos NT, Waldhausen JA, et al: Volume requirements for cardiac surgery credentialing: A critical examination. The Ad Hoc Committee on Cardiac Surgery Credentialing of The Society of Thoracic Surgeons. Ann Thorac Surg 1996;61:12–16.
  23. Williams SV, Nash DB, Goldfarb N: Differences in mortality from coronary artery bypass graft surgery at five teaching hospitals. JAMA 1991;266:810–815.
  24. Dudley R, Johansen K, Brand R, Rennie D, Milstein A: Selective referral to high-volume hospitals: Estimating potentially avoidable deaths. JAMA 2000;283:1159–1166.
  25. Birkmeyer JD: Should we regionalize major surgery? Potential benefits and policy considerations. J Am Coll Surg 2000;190:341–349.
  26. Birkmeyer JD: High-risk surgery – follow the crowd. JAMA 2000;283:1191–1193.
  27. Luft H, Bunker J, Enthoven A: Should operations be regionalized? The empirical relation between surgical volume and mortality. N Engl J Med 1979;301:1364–1369.
  28. Birkmeyer JD, Finlayson EV, Birkmeyer CM: Volume standards for high-risk surgical procedures: Potential benefits of the Leapfrog initiative. Surgery 2001;130:415–422.
  29. George R, Leibrock L, Epstein M: Long-term analysis of cerebrospinal fluid shunt infections: A 25-year experience. J Neurosurg 1979;51:804–811.
  30. Munoz E, Boiardo R, Mulloy K, Goldstein J, Tenenbaum N, Wise L: Economics of scale, physician volume for neurosurgery patients and the diagnosis related group prospective hospital payment system. Neurosurgery 1990;26:156–161.
  31. Kestle J, Drake J, Milner R, Sainte-Rose C, Cinalli G, Boop F, et al: Long-term follow-up data from the Shunt Design Trial. Pediatr Neurosurg 2000;33:230–236.
  32. Cox CE, Salud CJ, Cantor A, Bass SS, Peltz ES, Ebert MD, et al: Learning curves for breast cancer sentinel lymph node mapping based on surgical volume analysis. J Am Coll Surg 2001;193:593–600.
  33. Finlayson EV, Birkmeyer JD: Outcomes in vascular surgery: Volume versus certification. Surgery 2001;130:897–898.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50